证券代码：600807 证券简称：济高发展 公告编号：临2025-044 济南高新发展股份有限公司 第十一届董事会第二十四次临时会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 公司第十一届董事会第二十四次临时会议于2025年8月1日上午10点，在中国 （山东）自由贸易试验区济南片区经十东路7000号汉峪金融商务中心A4-4号楼11 层会议室，以现场和通讯结合方式召开，会议通知和材料于2025年7月28日以电 子通讯方式发出。应出席会议董事9名，实际出席会议董事9名，公司监事列席了 会议，符合《中华人民共和国公司法》等有关法律、行政法规、部门规章、规范 性文件和《公司章程》的规定。会议召集人、主持人为公司董事长王成东先生。 经投票表决，会议形成如下决议： 一、审议通过《关于审议修订<公司章程>并取消监事会的议案》。 具体内容详见同日披露的《关于修订<公司章程>并取消监事会及修订部分公 司治理制度的公告》；《济南高新发展股份有限公司章程》详见公司将于 2025 年 第三次临时股东大会召开前披露的股东大会会议材料。 表 ...

中国基金报7月25日电，济高发展（600807.SH）公告，控股股东之一济南东信开发建设有限公司因司 法裁定，所持公司1075.57万股股份（占比1.21%）已被全部被动减持。减持后控股股东合计持股比例由 28.92%降至27.71%。 ...

证券代码：600807 证券简称：济高发展 公告编号：临 2025-043 关于控股股东所持公司股份 权益变动触及 1%刻度的提示性公告 1.身份类别 | 投资者及其一致行动人的身份 | √控股股东/实际控制人及其一致行动人 | | --- | --- | | | □其他 5%以上大股东及其一致行动人 | 重要内容提示： 权益变动方向 比例增加□ 比例减少√ 权益变动前合计比例 28.92% 权益变动后合计比例 27.71% 本次变动是否违反已作出的承 诺、意向、计划 是□ 否√ 是否触发强制要约收购义务 是□ 否√ | □合并口径第一大股东及其一致行动人（仅适用 | 于无控股股东、实际控制人） | | --- | --- | | □其他 | | 2.信息披露义务人信息 | 信息披露义务人名称 | 投资者身份 | | 统一社会信用代码 | | --- | --- | --- | --- | | | √控股股东/实控人 | | | | 济南东信开发建设有 | □ | 控股股东/实控人的一致 | √913701004930016257 | | 限公司 | | 行动人 | □ 不适用 | | | □ | 其他直接持 ...

来源：环球网 为全面检验和提升防汛抗旱应急处置能力，切实保障人民群众生命财产安全，7月15日，城市管理部组 织开展2025年度防汛应急实战演练。此次演练由济南高新区防汛抗旱指挥部指挥长，济南综保区党工委 委员、管委会副主任丁勇同志担任总指挥，济南高新区防汛抗旱指挥部副指挥长，城市管理部党组书 记、部长张晓波同志担任副总指挥，区气象局、应急安全部、城市管理部、消防救援大队、交警大队、 供电中心、各街道办事处、章锦工作组负责同志以及特邀防汛专家和现场参演人员共计150余人参加演 练。 本次演练以突发性强降雨天气为背景，聚焦防汛抢险关键环节，设置黄河应急抢险、城区道路积水应急 处置、地下空间排水排涝、山洪预警及农村村民转移安置、河道抢险、机场周边排水渠积水处置、水上 救援、电力抢修等八大实战科目。演练过程全景式模拟了从灾害预报预警、应急指挥决策、抢险力量调 度、现场紧急处置到受威胁群众安全转移等防汛救灾工作全流程。 演练中，各参演单位协同作战、反应迅速，各环节衔接紧密、处置高效，有效检验了现有防汛应急预案 的科学性、实用性和可操作性。通过此次贴近实战的演练，全体参演人员进一步深化了对防汛救援重点 环节、处置要点与规 ...

Core Viewpoint - Jinan High-tech Development Co., Ltd. expects a net loss of approximately 45 million yuan for the first half of 2025, indicating an expanded loss compared to the same period last year [1][2]. Financial Performance - The company's net profit attributable to shareholders for the same period last year was -29.63 million yuan, showing a significant increase in losses [2]. - In 2024, the company's operating revenue was 372 million yuan, a decrease of 48.0% year-on-year, while the net profit attributable to shareholders worsened from -95.10 million yuan in 2023 to -806 million yuan [5]. Business Operations - The main business of the company is in in vitro diagnostics, with additional involvement in trade, real estate, and property services [6]. - In 2024, the revenue from the in vitro diagnostics business was 160 million yuan, a decline of 56.51% compared to the previous year, with a decrease in operating costs by 50.17% and a drop in gross margin by 9.68% [6]. - The company attributes the decline in its in vitro diagnostics revenue to the overall market environment and its own business operations, particularly the performance of its subsidiary, Aikwei Biomedical [6]. Legal Issues - The company has disclosed multiple updates regarding litigation progress throughout the year, which have contributed to the negative net profit, primarily due to contractual negligence and debt disputes, leading to estimated compensation losses of approximately 40 million yuan [5].

证券代码：600807 证券简称：济高发展 公告编号：临 2025-042 济南高新发展股份有限公司 2025 年半年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 1、业绩预告适用情形：净利润为负值。 2、经公司财务部门初步测算，预计 2025 年半年度实现归属于上市公司股东 的净利润约-4,500 万元，预计将出现亏损。 3、公司预计 2025 年半年度实现归属于上市公司股东的扣除非经常性损益的 净利润约-2,500 万元。 一、本期业绩预告情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 6 月 30 日。 （二）业绩预告情况 1、经公司财务部门初步测算，预计 2025 年半年度实现归属于上市公司股东 的净利润约-4,500 万元，预计将出现亏损。 2、公司预计 2025 年半年度实现归属于上市公司股东的扣除非经常性损益的 净利润约-2,500 万元。 二、上年同期经营业绩和财务状况 （一）利润总额为-3,360.90万元；归属于上市公司股东的净利润为 -2,963.39 ...

Core Viewpoint - JG Development (600807) is expected to report a net loss of approximately 45 million yuan for the first half of 2025, indicating a challenging financial outlook for the company [1] Financial Performance - The company anticipates a net profit attributable to shareholders of approximately -45 million yuan for the first half of 2025 [1] - The expected net profit, excluding non-recurring gains and losses, is projected to be around -25 million yuan [1]

Market Overview - The Shanghai Composite Index closed at 3473.13 points, slightly above the annual line, with a change of 0.02% [1] - The total trading volume of A-shares reached 1,227.067 billion yuan [1] Stocks Breaking Annual Line - A total of 69 A-shares have surpassed the annual line today, with notable stocks showing significant deviation rates [1] - Stocks with the highest deviation rates include: - Guotou Zhonglu (8.45%) - Jihigh Development (6.51%) - Huate Gas (5.29%) [1] Detailed Stock Performance - The following stocks have notable performance metrics: - Guotou Zhonglu: Today's change of 9.98%, turnover rate of 0.15%, latest price at 14.77 yuan [1] - Jihigh Development: Today's change of 10.16%, turnover rate of 5.09%, latest price at 3.36 yuan [1] - Huate Gas: Today's change of 5.31%, turnover rate of 3.79%, latest price at 50.99 yuan [1] - Other stocks with smaller deviation rates include: - Xinwufeng - Sanfeng Environment - Yunnan Energy Investment [1]

Core Viewpoint - The A-share market shows a slight decline with the Shanghai Composite Index at 3468.65 points, down by 0.11%, while the total trading volume reached 584.993 billion yuan, indicating a mixed performance in the market [1]. Group 1: Market Performance - As of 10:29 AM, the Shanghai Composite Index is at 3468.65 points, with a decrease of 0.11% [1]. - The total trading volume in the A-share market is 584.993 billion yuan [1]. Group 2: Stocks Breaking the Annual Line - A total of 46 A-shares have surpassed the annual line today, with notable stocks including Guotou Zhonglu, Jigaofazhan, and Huate Gas, showing significant deviation rates of 8.45%, 6.51%, and 4.34% respectively [1]. - Stocks with smaller deviation rates that have just crossed the annual line include Pudong Jinqiao, Hengli Petrochemical, and Zhenyou Technology [1]. Group 3: Top Stocks by Deviation Rate - The top three stocks with the highest deviation rates are: - Guotou Zhonglu (Code: 600962) with a price increase of 9.98% and a deviation rate of 8.45% [1]. - Jigaofazhan (Code: 600807) with a price increase of 10.16% and a deviation rate of 6.51% [1]. - Huate Gas (Code: 688268) with a price increase of 4.36% and a deviation rate of 4.34% [1]. Group 4: Additional Stocks with Positive Performance - Other notable stocks with positive performance include: - Jingtou Fazhan (Code: 600683) with a price increase of 4.39% and a deviation rate of 2.45% [1]. - Huaihe Energy (Code: 600575) with a price increase of 2.23% and a deviation rate of 1.96% [1]. - ST Gaosi (Code: 002848) with a price increase of 2.88% and a deviation rate of 1.65% [1]. Group 5: Stocks with Lower Deviation Rates - Stocks with lower deviation rates that have recently crossed the annual line include: - Qianyuan Qian (Code: 600189) with a price increase of 1.80% and a deviation rate of 0.82% [2]. - Sifang Stock (Code: 601126) with a price increase of 0.79% and a deviation rate of 0.72% [2]. - Wentai Technology (Code: 600745) with a price increase of 0.94% and a deviation rate of 0.66% [2].

Meeting Overview - The shareholders' meeting was held on June 20, 2025, at the financial business center in Jinan, Shandong, China [2] - The meeting was convened by the board of directors, with over half of the directors present, and was chaired by Director Sun Yingcai [3][4] Voting and Resolutions - All proposed resolutions were approved, including the annual reports from the board and supervisory committee for 2024, financial settlement report, and profit distribution plan [5][6] - Specific resolutions included the evaluation of internal controls, asset impairment provisions, and financing applications for 2025 [6][7] - The meeting also involved separate voting for certain resolutions affecting minority investors and noted that related party transactions were abstained from by relevant shareholders [8][9] Legal Compliance - The meeting was witnessed by lawyers from Beijing Dacheng (Jinan) Law Firm, confirming that the procedures followed were in compliance with legal and regulatory requirements [10]